3 studies found for:    "NJMS" OR "New Jersey Medical School" | Open Studies | "Hemostatic Disorders"
Show Display Options
Rank Status Study
1 Recruiting Atorvastatin on Biomarkers of Inflammation, Coagulopathy, Angiogenesis & T-cells
Condition: HIV-1 Infection
Intervention: Drug: atorvastatin
2 Recruiting Lenalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Multiple Myeloma
Conditions: Stage I Multiple Myeloma;   Stage II Multiple Myeloma;   Stage III Multiple Myeloma
Interventions: Drug: bortezomib;   Drug: dexamethasone;   Drug: lenalidomide
3 Recruiting Melphalan, Prednisone, and Thalidomide or Lenalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma
Conditions: Stage I Multiple Myeloma;   Stage II Multiple Myeloma;   Stage III Multiple Myeloma
Interventions: Drug: melphalan;   Drug: prednisone;   Drug: thalidomide;   Drug: lenalidomide

Indicates status has not been verified in more than two years